Latest news for Appreciate Holdings (OTC:SFRT) Stock

Appreciate Holdings Inc through its operating company Renters Warehouse offers an end-to-end Single Family Rental marketplace and management platform. The company offers a full-service platform for investing in and owning SFR properties, including a proprietary online marketplace and full-service brokerage teams.

APPRECIATE HLDGS INC A by Appreciate Holdings, Inc.

Appreciate Holdings Inc

Appreciate Holdings Inc Warrants (08/12/2027)

News

Health Care

General

Conduit Pharmaceuticals Announces Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>)&nbsp;reported a second-quarter fiscal 2024 net income of $6.9 billion and EPS of $0.83, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $0.80</a>.
Revenue, net of interest expense, increased 0.8% year-over-year to $25.54 billion, beating the analyst consensus estimate of&nbsp;<a target="_blank" href="https://investor.bankofamerica.com/quarterly-earnings" rel="noreferrer noopener">$25.22 billion</a>.
Segment Net income: Consumer Banking $2.595 billion vs. $2.853 billion Y/Y, Global Wealth and Investment Management $1.03 billion vs. $978 million Y/Y, Global Banking $2.12 billion vs. $2.65 billion Y/Y, and Global Markets $1.41 billion vs. $1.18 billion Y/Y.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/24/06/39563519/us-banks-bump-up-dividends-following-feds-successful-stress-test" rel="noreferrer noopener">US Banks Bump Up Dividends Following Fed's Successful Stress Test</a>
The Net interest income was $13.7 billion (-3.0% Y/Y), as higher deposit costs more than offset higher asset yields and modest loan growth. Noninterest income was $11.7 billion (+6.0% Y/Y). Provision for credit losses was $1.5 billion, compared to $1.1 billion a year ago.
The efficiency ratio for the quarter was 64%, flat Y/Y. The bank reported a CET1 ratio of 11.9%, up 30 bps from a year ago. The book value per share of $34.39 improved by 7%.
The average loan and lease balance was $1.05 trillion (+0.5% Y/Y). Average deposits are up 2% Y/Y to $1.91 trillion.
Bank of America added ~1.0 million credit card accounts during the quarter.
Dividend: From CFO Alastair Borthwick: "We announced plans for an eight percent increase in our quarterly common stock dividend, to 26 cents per share, pending Board approval."
Outlook: Bank of America anticipates net interest income of ~$14.50 billion in the fourth quarter. It assumes a 25 bps interest rate cut.
Price Action: BAC shares are trading higher by 2.41% at $42.90 premarket at the last check Tuesday.
Photo Courtesy: Tero Vesalainen On Shutterstock

Earnings

Dividends

Movers

Bank of America's Q2 Earnings: Revenue And EPS Beat, $1.5B Credit Loss Provision, Sees Q4 NII Growth

Mizuho analyst Gregg Moskowitz maintains Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>) with a Outperform and lowers the price target from $36 to $34.

Price Target

Analyst Ratings

CFLT

Mizuho Maintains Outperform on Confluent, Lowers Price Target to $34

Guidance

Bank Of America Sees Q4 NII ~$14.5B

Mizuho analyst Gregg Moskowitz maintains Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) with a Neutral and raises the price target from $88 to $92.

Mizuho Maintains Neutral on Cloudflare, Raises Price Target to $92

Mizuho analyst Gregg Moskowitz maintains Atlassian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) with a Outperform and lowers the price target from $225 to $220.

TEAM

Mizuho Maintains Outperform on Atlassian, Lowers Price Target to $220

Needham analyst Scott Berg reiterates SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) with a Buy and maintains $18 price target.

Reiteration

SEMR

Needham Reiterates Buy on SEMrush Hldgs, Maintains $18 Price Target

<ul>
<li>300 patients enrolled in the study, including patients with and without the cognitive biomarker &ndash;</li>
<li>On track to report topline data in October 2024 &ndash;</li>
<li>Alto to host investor day focused on ALTO-100 on September 9, 2024 &ndash;</li>
</ul>

ANRO

Alto Neuroscience Completes Enrollment In ALTO-100 Phase 2b Study, Topline Results Expected In October

Redwire Secures Follow-On Order For Roll-Out Solar Arrays For Thales Alenia Space's Newest Telecommunications Satellite Product Line

WIIM

State Street shares are trading higher following better-than-expected Q2 financial results.

State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) reported quarterly earnings of $2.15 per share which beat the analyst consensus estimate of $2.03 by 5.91 percent. The company reported quarterly sales of $3.191 billion which beat the analyst consensus estimate of $3.146 billion by 1.42 percent. This is a 2.60 percent increase over sales of $3.110 billion the same period last year.

Earnings Beats

State Street Q2 2024 GAAP EPS $2.15 Beats $2.03 Estimate, Total Revenue $3.191B Beat $3.146B Estimate

MDWD

MediWound Selected For €16.25M Funding From The European Innovation Council Accelerator Program

Morgan Stanley analyst Mike Cyprys maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $1013 to $1036.

Morgan Stanley Maintains Overweight on BlackRock, Raises Price Target to $1036

Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.72 by 1.39 percent. The company reported quarterly sales of $4.69 billion which beat the analyst consensus estimate of $4.68 billion by 0.20 percent. This is a 0.73 percent increase over sales of $4.66 billion the same period last year.

SCHW

Charles Schwab Q2 2024 Adj EPS $0.73 Beats $0.72 Estimate, Sales $4.69B Beat $4.68B Estimate

Morgan Stanley shares are trading higher following better-than-expected Q2 earnings.

Philip Morris International U.S. Affiliate To Create 500 Jobs Investing $600M In Colorado Manufacturing Facility

Biotech

BTAI

BioXcel Therapeutics Announced Preliminary Sales Of Igalmi (Dexmedetomidine) Sublingual Film For Q2 Of Approximately $1.1M, Up Approximately 90% Quarter Over Quarter And Approximately 141% Year-over-year

Morgan Stanley Raises Dividend From $0.85 To $0.925/Share

Morgan Stanley analyst Betsy Graseck maintains Goldman Sachs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) with a Overweight and raises the price target from $475 to $513.

Morgan Stanley Maintains Overweight on Goldman Sachs Gr, Raises Price Target to $513

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) reported quarterly earnings of $1.82 per share which beat the analyst consensus estimate of $1.65 by 10.3 percent. The company reported quarterly sales of $15.00 billion which beat the analyst consensus estimate of $14.30 billion by 4.90 percent. This is a 11.47 percent increase over sales of $13.46 billion the same period last year.

Morgan Stanley Q2 2024 Adj EPS $1.82 Beats $1.65 Estimate, Sales $15.00B Beat $14.30B Estimate

D.A. Davidson analyst Tom White maintained a Buy rating on Appreciate Holdings (SFRT – Research Report) today. The company's shares closed last Fri...